Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neuropeptide Y gene encodes neuropeptide Y, a 36-amino acid peptide neurotransmitter widely expressed in the central and peripheral nervous systems. NPY plays key roles in the regulation of feeding behavior, energy homeostasis, neuroendocrine secretion, and stress responses[1][2][3][4]. Its expression is tightly regulated by physiological and environmental factors, such as fasting, stress, and hormonal signals (e.g., leptin, nerve growth factor)[2][3][5]. Downregulation of NPY gene expression is a biological process relevant to appetite suppression and obesity therapeutics[3].
For drugs targeting NPY pathways: receptor antagonism (Y1, Y2, Y5), antisense inhibition (experimental), gene silencing (experimental/therapeutic RNAi approaches)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuropeptide Y (gene) (NPY).